Therapeutic Classification

nsaid Registry

Clinical reference for nsaid medications. Access safety monographs, dosing adjustments, and drug-drug interactions for all registered brand names and generics in this class.

Registered Medications (nsaid)

Medication	Therapeutic Class	Maternal Safety
8-HOUR BAYER Aspirin should be avoided during pregnancy, especially in the third trimester (risk of premature closure of ductus arteriosus, oligohydramnios, and bleeding). Low-dose aspirin (81 mg/day) may be used for high-risk conditions (e.g., preeclampsia prevention) under medical supervision.	NSAID	caution
ACETAMINOPHEN AND IBUPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
ACETAMINOPHEN, ASPIRIN AND CAFFEINE Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.	NSAID / Antiplatelet	avoid
ACTRON Comprehensive clinical and safety monograph for ACTRON (ACTRON).	NSAID	caution
ACULAR Comprehensive clinical and safety monograph for ACULAR (ACULAR).	NSAID Ophthalmic	caution
ACULAR LS Comprehensive clinical and safety monograph for ACULAR LS (ACULAR LS).	NSAID Ophthalmic	caution
ACULAR PRESERVATIVE FREE Comprehensive clinical and safety monograph for ACULAR PRESERVATIVE FREE (ACULAR PRESERVATIVE FREE).	NSAID Ophthalmic	caution
ACUVAIL Comprehensive clinical and safety monograph for ACUVAIL (ACUVAIL).	NSAID Ophthalmic	caution
ADVIL Comprehensive clinical and safety monograph for ADVIL (ADVIL).	NSAID	caution
ADVIL ALLERGY AND CONGESTION RELIEF Comprehensive clinical and safety monograph for ADVIL ALLERGY AND CONGESTION RELIEF (ADVIL ALLERGY AND CONGESTION RELIEF).	NSAID/Decongestant Combination	caution
ADVIL ALLERGY SINUS Comprehensive clinical and safety monograph for ADVIL ALLERGY SINUS (ADVIL ALLERGY SINUS).	NSAID/Decongestant/Antihistamine Combination	caution
ADVIL COLD AND SINUS Comprehensive clinical and safety monograph for ADVIL COLD AND SINUS (ADVIL COLD AND SINUS).	NSAID/Decongestant Combination	caution
ADVIL CONGESTION RELIEF Comprehensive clinical and safety monograph for ADVIL CONGESTION RELIEF (ADVIL CONGESTION RELIEF).	NSAID/Decongestant Combination	caution
ADVIL DUAL ACTION WITH ACETAMINOPHEN Comprehensive clinical and safety monograph for ADVIL DUAL ACTION WITH ACETAMINOPHEN (ADVIL DUAL ACTION WITH ACETAMINOPHEN).	NSAID/Analgesic Combination	caution
ADVIL LIQUI-GELS Comprehensive clinical and safety monograph for ADVIL LIQUI-GELS (ADVIL LIQUI-GELS).	NSAID	caution
ADVIL MIGRAINE LIQUI-GELS Comprehensive clinical and safety monograph for ADVIL MIGRAINE LIQUI-GELS (ADVIL MIGRAINE LIQUI-GELS).	NSAID	caution
ADVIL PM Comprehensive clinical and safety monograph for ADVIL PM (ADVIL PM).	NSAID/Sedative Combination	caution
ALEVE Comprehensive clinical and safety monograph for ALEVE (ALEVE).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
ALEVE PM Comprehensive clinical and safety monograph for ALEVE PM (ALEVE PM).	NSAID/Antihistamine Combination	caution
ALEVE-D SINUS & COLD Comprehensive clinical and safety monograph for ALEVE-D SINUS & COLD (ALEVE-D SINUS & COLD).	NSAID/Decongestant Combination	caution
ANAPROX Comprehensive clinical and safety monograph for ANAPROX (ANAPROX).	NSAID	caution
ANAPROX DS Comprehensive clinical and safety monograph for ANAPROX DS (ANAPROX DS).	NSAID	caution
ANJESO Comprehensive clinical and safety monograph for ANJESO (ANJESO).	NSAID	caution
ANSAID Comprehensive clinical and safety monograph for ANSAID (ANSAID).	NSAID	caution
ARTHROTEC Comprehensive clinical and safety monograph for ARTHROTEC (ARTHROTEC).	NSAID	caution
Aspirin Aspirin has a profoundly dose-dependent safety and indication profile in pregnancy that mandates clear clinical distinction between low-dose (75–100 mg/day, antiplatelet) and high-dose (≥325 mg, analgesic/anti-inflammatory) use. Low-dose aspirin (LDA) is a cornerstone intervention in obstetric medicine: ACOG, USPSTF (Grade B recommendation), WHO, NICE, and FIGO all recommend initiating LDA at 12–16 weeks gestation (optimally before 16 weeks, ideally by 12 weeks) in women at increased risk of preeclampsia, reducing its incidence by approximately 10–24% overall and by up to 62% when initiated before 16 weeks in high-risk women (ASPRE trial). LDA is also used for antiphospholipid syndrome (APS), prevention of recurrent pregnancy loss in APS, and thromboprophylaxis in specific haematological conditions. High-dose aspirin functions as a full NSAID and carries the class risks of premature closure of the ductus arteriosus (particularly after 20 weeks, critically so after 32 weeks), fetal renal impairment, oligohydramnios, inhibition of labour, and maternal and fetal haemostatic compromise. High-dose aspirin should be avoided after 20 weeks of gestation and is contraindicated after 32 weeks. The FDA issued a Drug Safety Communication in 2020 strengthening warnings against NSAID use (including high-dose aspirin) from 20 weeks onwards.	NSAID / Antiplatelet	caution
AZOLID Comprehensive clinical and safety monograph for AZOLID (AZOLID).	NSAID	caution
BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.	NSAID / Antiplatelet	avoid
BEXTRA Comprehensive clinical and safety monograph for BEXTRA (BEXTRA).	COX-2 Inhibitor NSAID	caution
BROMDAY Comprehensive clinical and safety monograph for BROMDAY (BROMDAY).	Ophthalmic NSAID	caution
BROMFENAC SODIUM Comprehensive clinical and safety monograph for BROMFENAC SODIUM (BROMFENAC SODIUM).	Ophthalmic NSAID	caution
BROMSITE Comprehensive clinical and safety monograph for BROMSITE (BROMSITE).	Ophthalmic NSAID	caution
BUTALBITAL, ASPIRIN AND CAFFEINE Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.	NSAID / Antiplatelet	avoid
BUTAZOLIDIN Comprehensive clinical and safety monograph for BUTAZOLIDIN (BUTAZOLIDIN).	NSAID	caution
CALDOLOR Comprehensive clinical and safety monograph for CALDOLOR (CALDOLOR).	NSAID	caution
CAMBIA Comprehensive clinical and safety monograph for CAMBIA (CAMBIA).	NSAID	caution
CAP-PROFEN Comprehensive clinical and safety monograph for CAP-PROFEN (CAP-PROFEN).	Opioid and NSAID Combination	caution
CELEBREX Comprehensive clinical and safety monograph for CELEBREX (CELEBREX).	NSAID (COX-2 Inhibitor)	caution
CHILDREN'S ADVIL Comprehensive clinical and safety monograph for CHILDREN'S ADVIL (CHILDREN'S ADVIL).	NSAID	caution
CHILDREN'S ADVIL-FLAVORED Comprehensive clinical and safety monograph for CHILDREN'S ADVIL-FLAVORED (CHILDREN'S ADVIL-FLAVORED).	NSAID	caution
CHILDREN'S ELIXSURE Comprehensive clinical and safety monograph for CHILDREN'S ELIXSURE (CHILDREN'S ELIXSURE).	NSAID	caution
CHILDREN'S IBUPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
CHILDREN'S MOTRIN Comprehensive clinical and safety monograph for CHILDREN'S MOTRIN (CHILDREN'S MOTRIN).	NSAID	caution
CLINORIL Comprehensive clinical and safety monograph for CLINORIL (CLINORIL).	NSAID	caution
COMBUNOX Comprehensive clinical and safety monograph for COMBUNOX (COMBUNOX).	Analgesic Combination (Opioid + NSAID)	caution
COMPOUND 65 Comprehensive clinical and safety monograph for COMPOUND 65 (COMPOUND 65).	Analgesic Combination (Opioid + NSAID)	caution
CONSENSI Comprehensive clinical and safety monograph for CONSENSI (CONSENSI).	Antihypertensive/NSAID Combination	caution
COXANTO Comprehensive clinical and safety monograph for COXANTO (COXANTO).	NSAID	caution
DAYPRO Comprehensive clinical and safety monograph for DAYPRO (DAYPRO).	Nonsteroidal Anti-Inflammatory Drug (NSAID)	caution
DAYPRO ALTA Comprehensive clinical and safety monograph for DAYPRO ALTA (DAYPRO ALTA).	Nonsteroidal Anti-Inflammatory Drug (NSAID)	caution
DICLOFENAC ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
DICLOFENAC POTASSIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
DICLOFENAC SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
DIFLUNISAL Comprehensive clinical and safety monograph for DIFLUNISAL (DIFLUNISAL).	NSAID	caution
DUEXIS Comprehensive clinical and safety monograph for DUEXIS (DUEXIS).	NSAID/H2 Antagonist Combination	caution
DYCLOPRO Comprehensive clinical and safety monograph for DYCLOPRO (DYCLOPRO).	NSAID	caution
DYLOJECT Comprehensive clinical and safety monograph for DYLOJECT (DYLOJECT).	NSAID	caution
EC-NAPROSYN Comprehensive clinical and safety monograph for EC-NAPROSYN (EC-NAPROSYN).	NSAID	caution
ELYXYB Comprehensive clinical and safety monograph for ELYXYB (ELYXYB).	NSAID (COX-2 Inhibitor)	caution
ETODOLAC ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
ETYQA Comprehensive clinical and safety monograph for ETYQA (ETYQA).	COX-2 Inhibitor NSAID	caution
EYDENZELT Comprehensive clinical and safety monograph for EYDENZELT (EYDENZELT).	NSAID	caution
FENOPROFEN CALCIUM Comprehensive clinical and safety monograph for FENOPROFEN CALCIUM (FENOPROFEN CALCIUM).	NSAID	caution
FLECTOR Comprehensive clinical and safety monograph for FLECTOR (FLECTOR).	Topical NSAID	caution
FLURBIPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
FLURBIPROFEN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
FYAVOLV Comprehensive clinical and safety monograph for FYAVOLV (FYAVOLV).	Topical NSAID	caution
HYDROCODONE BITARTRATE AND IBUPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
IBTROZI Comprehensive clinical and safety monograph for IBTROZI (IBTROZI).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
IBU Comprehensive clinical and safety monograph for IBU (IBU).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
IBU-TAB Comprehensive clinical and safety monograph for IBU-TAB (IBU-TAB).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
IBU-TAB 200 Comprehensive clinical and safety monograph for IBU-TAB 200 (IBU-TAB 200).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
IBUPRIN Comprehensive clinical and safety monograph for IBUPRIN (IBUPRIN).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
Ibuprofen Avoid, especially after 20 weeks gestation. Associated with premature closure of the ductus arteriosus and fetal renal dysfunction leading to oligohydramnios. The FDA strengthened its warning in 2020 to include all NSAIDs from 20 weeks onward. Some studies suggest a modest increase in early miscarriage risk with first-trimester use, though evidence is not definitive.	NSAID	avoid
IBUPROFEN AND DIPHENHYDRAMINE CITRATE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
IBUPROFEN AND FAMOTIDINE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
IBUPROFEN AND PHENYLEPHRINE HYDROCHLORIDE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
IBUPROFEN LYSINE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
IBUPROFEN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
IBUPROHM Comprehensive clinical and safety monograph for IBUPROHM (IBUPROHM).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
IBUPROHM COLD AND SINUS Comprehensive clinical and safety monograph for IBUPROHM COLD AND SINUS (IBUPROHM COLD AND SINUS).	NSAID/Decongestant Combination	caution
ILEVRO Comprehensive clinical and safety monograph for ILEVRO (ILEVRO).	Ophthalmic NSAID	caution
INDICLOR Comprehensive clinical and safety monograph for INDICLOR (INDICLOR).	NSAID	caution
INDO-LEMMON Comprehensive clinical and safety monograph for INDO-LEMMON (INDO-LEMMON).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
INDOCIN Comprehensive clinical and safety monograph for INDOCIN (INDOCIN).	NSAID	caution
INDOCIN SR Comprehensive clinical and safety monograph for INDOCIN SR (INDOCIN SR).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
INDOMETHACIN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
INDOMETHACIN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
INFANT'S ADVIL Comprehensive clinical and safety monograph for INFANT'S ADVIL (INFANT'S ADVIL).	NSAID	caution
IVRA Comprehensive clinical and safety monograph for IVRA (IVRA).	Nonsteroidal Anti-Inflammatory Drug (NSAID)	caution
JUNIOR STRENGTH ADVIL Comprehensive clinical and safety monograph for JUNIOR STRENGTH ADVIL (JUNIOR STRENGTH ADVIL).	NSAID Analgesic	caution
JUNIOR STRENGTH IBUPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
JUNIOR STRENGTH MOTRIN Comprehensive clinical and safety monograph for JUNIOR STRENGTH MOTRIN (JUNIOR STRENGTH MOTRIN).	NSAID Analgesic	caution
KETOPROFEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
KETOROLAC TROMETHAMINE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious bleeding and renal impairment.	NSAID	avoid
KETOROLAC TROMETHAMINE AND PHENYLEPHRINE HYDROCHLORIDE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious bleeding and renal impairment.	NSAID	avoid
LODINE Comprehensive clinical and safety monograph for LODINE (LODINE).	NSAID	caution
LODINE XL Comprehensive clinical and safety monograph for LODINE XL (LODINE XL).	NSAID	caution
MEASURIN Comprehensive clinical and safety monograph for MEASURIN (MEASURIN).	NSAID	caution
MECLOFENAMATE SODIUM Comprehensive clinical and safety monograph for MECLOFENAMATE SODIUM (MECLOFENAMATE SODIUM).	NSAID	caution
MECLOMEN Comprehensive clinical and safety monograph for MECLOMEN (MECLOMEN).	NSAID	caution
MEFENAMIC ACID ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
MELOXICAM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
MEPRO-ASPIRIN Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.	NSAID / Antiplatelet	avoid
MEPROBAMATE AND ASPIRIN Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.	NSAID / Antiplatelet	avoid
MOTRIN Comprehensive clinical and safety monograph for MOTRIN (MOTRIN).	NSAID Analgesic	caution
MOTRIN IB Comprehensive clinical and safety monograph for MOTRIN IB (MOTRIN IB).	NSAID Analgesic	caution
MOTRIN MIGRAINE PAIN Comprehensive clinical and safety monograph for MOTRIN MIGRAINE PAIN (MOTRIN MIGRAINE PAIN).	NSAID Analgesic	caution
NABUMETONE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
NALFON Comprehensive clinical and safety monograph for NALFON (NALFON).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
NAPRELAN Comprehensive clinical and safety monograph for NAPRELAN (NAPRELAN).	NSAID	caution
NAPROSYN Comprehensive clinical and safety monograph for NAPROSYN (NAPROSYN).	NSAID	caution
NAPROXEN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
NAPROXEN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
NEOPROFEN Comprehensive clinical and safety monograph for NEOPROFEN (NEOPROFEN).	NSAID	caution
NEVANAC Comprehensive clinical and safety monograph for NEVANAC (NEVANAC).	NSAID Ophthalmic	caution
OCUFEN Comprehensive clinical and safety monograph for OCUFEN (OCUFEN).	Ophthalmic NSAID	caution
OMIDRIA Comprehensive clinical and safety monograph for OMIDRIA (OMIDRIA).	Ophthalmic NSAID and Mydriatic Combination	caution
ONMEL Comprehensive clinical and safety monograph for ONMEL (ONMEL).	NSAID	caution
ORUDIS Comprehensive clinical and safety monograph for ORUDIS (ORUDIS).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
ORUDIS KT Comprehensive clinical and safety monograph for ORUDIS KT (ORUDIS KT).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
ORUVAIL Comprehensive clinical and safety monograph for ORUVAIL (ORUVAIL).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
OXAPROZIN ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
PEDIATRIC ADVIL Comprehensive clinical and safety monograph for PEDIATRIC ADVIL (PEDIATRIC ADVIL).	NSAID	caution
PENNSAID Comprehensive clinical and safety monograph for PENNSAID (PENNSAID).	Topical NSAID	caution
PHENYLBUTAZONE Comprehensive clinical and safety monograph for PHENYLBUTAZONE (PHENYLBUTAZONE).	NSAID	caution
PIROXICAM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
PREVACID NAPRAPAC 250 (COPACKAGED) Comprehensive clinical and safety monograph for PREVACID NAPRAPAC 250 (COPACKAGED) (PREVACID NAPRAPAC 250 (COPACKAGED)).	Proton Pump Inhibitor/NSAID Combination	caution
PREVACID NAPRAPAC 375 (COPACKAGED) Comprehensive clinical and safety monograph for PREVACID NAPRAPAC 375 (COPACKAGED) (PREVACID NAPRAPAC 375 (COPACKAGED)).	Proton Pump Inhibitor/NSAID Combination	caution
PREVACID NAPRAPAC 500 (COPACKAGED) Comprehensive clinical and safety monograph for PREVACID NAPRAPAC 500 (COPACKAGED) (PREVACID NAPRAPAC 500 (COPACKAGED)).	Proton Pump Inhibitor/NSAID Combination	caution
PROFENAL Comprehensive clinical and safety monograph for PROFENAL (PROFENAL).	NSAID	caution
PROLENSA Comprehensive clinical and safety monograph for PROLENSA (PROLENSA).	Ophthalmic NSAID	caution
PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.	NSAID / Antiplatelet	avoid
RELAFEN Comprehensive clinical and safety monograph for RELAFEN (RELAFEN).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
RIMADYL Comprehensive clinical and safety monograph for RIMADYL (RIMADYL).	Nonsteroidal Anti-inflammatory Drug (NSAID)	caution
RUFEN Comprehensive clinical and safety monograph for RUFEN (RUFEN).	Nonsteroidal Anti-Inflammatory Drug (NSAID)	caution
SINE-AID IB Comprehensive clinical and safety monograph for SINE-AID IB (SINE-AID IB).	Combination NSAID/antihistamine	caution
SOLARAZE Comprehensive clinical and safety monograph for SOLARAZE (SOLARAZE).	NSAID	caution
SPRIX Comprehensive clinical and safety monograph for SPRIX (SPRIX).	NSAID Analgesic	caution
SULINDAC ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
TAB-PROFEN Comprehensive clinical and safety monograph for TAB-PROFEN (TAB-PROFEN).	NSAID	caution
TENATHAN Comprehensive clinical and safety monograph for TENATHAN (TENATHAN).	NSAID	caution
TOLECTIN Comprehensive clinical and safety monograph for TOLECTIN (TOLECTIN).	NSAID	caution
TOLECTIN 600 Comprehensive clinical and safety monograph for TOLECTIN 600 (TOLECTIN 600).	NSAID	caution
TOLECTIN DS Comprehensive clinical and safety monograph for TOLECTIN DS (TOLECTIN DS).	NSAID	caution
TOLMETIN SODIUM ACE inhibitors and ARBs may have diminished antihypertensive effect Increases risk of serious cardiovascular thrombotic events and GI bleeding.	NSAID	avoid
TORADOL Comprehensive clinical and safety monograph for TORADOL (TORADOL).	NSAID (Ketorolac)	caution
VAZALORE Comprehensive clinical and safety monograph for VAZALORE (VAZALORE).	NSAID	caution
VIMOVO Comprehensive clinical and safety monograph for VIMOVO (VIMOVO).	NSAID/PPI Combination	caution
VIOXX Comprehensive clinical and safety monograph for VIOXX (VIOXX).	NSAID (COX-2 Inhibitor)	caution
VIVLODEX Comprehensive clinical and safety monograph for VIVLODEX (VIVLODEX).	NSAID	caution
VOLTAREN Comprehensive clinical and safety monograph for VOLTAREN (VOLTAREN).	NSAID	caution
VOLTAREN ARTHRITIS PAIN Comprehensive clinical and safety monograph for VOLTAREN ARTHRITIS PAIN (VOLTAREN ARTHRITIS PAIN).	NSAID (Topical)	caution
VOLTAREN-XR Comprehensive clinical and safety monograph for VOLTAREN-XR (VOLTAREN-XR).	NSAID	caution
XIBROM Comprehensive clinical and safety monograph for XIBROM (XIBROM).	NSAID	caution
ZIPSOR Comprehensive clinical and safety monograph for ZIPSOR (ZIPSOR).	NSAID	caution
ZORVOLEX Comprehensive clinical and safety monograph for ZORVOLEX (ZORVOLEX).	NSAID	caution
ZYNRELEF KIT Comprehensive clinical and safety monograph for ZYNRELEF KIT (ZYNRELEF KIT).	Local Anesthetic and NSAID Combination	caution

This therapeutic registry is dynamically synthesized from professional clinical sources. Listing of a medication does not imply equivalence; refer to individual monographs for head-to-head pharmacological data.